(PharmaNewsWire.Com, February 26, 2020 ) The global Mice Model Market was valued at USD 1.1 billion in 2016 and is projected to reach USD 1.6 billion by 2021, at a CAGR of 7.5% during the forecast period. Ongoing innovations in mice models, the growing demand for personalized medicine, the increasing number of pharmaceutical R&D activities, and the rising focus of associations on the development of embryonic stem cells as well as knockout and mutant mice are the major factors that are expected to drive the growth of the global mice model market during the forecast period.
The inbred mice segment accounted for the largest share of the mice model market, by type, in 2016
Inbred mice, genetically engineered mice, conditioned/surgically modified mice, hybrid/congenic mice, outbred mice, and spontaneous mutant mice are the different types of mice models covered in this report. In 2016, the inbred mice segment dominated the mice model market, and this trend is expected to continue during the forecast period. This can primarily be attributed to the growing number of biomedical research activities where inbred mice are used widely for various biomedical experiments.
CRISPR/Cas9 is the fastest-growing technology segment in the mice model market
Based on the technology used to create transgenic mice, the market is segmented into CRISPR/Cas9, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies. CRISPR/Cas9 is the most widely used technology to create transgenic mice owing to its advantages, such as high efficiency, ease of design, and relatively lower cost. Owing to its extensive usage, CRISPR/Cas9 is expected to be the largest and the fastest-growing technology segment in the mice model market during the forecast period.
The cages segment dominated the mice care products market in 2016
The mice care products market includes bedding, cages, feed, and other products. In 2016, cages dominated this market owing to their higher cost as compared to other mice care products. The demand for cages as well as other mice care products is driven primarily by the implementation of guidelines that state specific requirements for the welfare of laboratory animals, including the timely replacement of old equipment, such as cages, with new ones.
North America dominated the global mice model market in 2016
The global mice model market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. In 2016, North America accounted for the largest share of this market majorly due to the growth in biomedical research in the US, rising preclinical activities by CROs and pharmaceutical companies, and growing stem cell research in Canada.
Charles River Laboratories International, Inc. (US), The Jackson Laboratory (US), Taconic Biosciences, Inc. (US), Envigo (UK), Laboratory Corporation of America Holdings (US), JANVIER LABS (France), Harbour BioMed (China), TRANSGENIC, Inc. (Japan), genOway (France), and Horizon Discovery Group plc (US) are some of the key players operating in this market.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
